Hvid, Lars G. http://orcid.org/0000-0003-3233-0429
Stenager, Egon http://orcid.org/0000-0002-4877-5193
Dalgas, Ulrik http://orcid.org/0000-0003-4132-2789
Funding for this research was provided by:
Sanofi Genzyme
Article History
Received: 18 January 2022
Revised: 7 April 2022
Accepted: 8 April 2022
First Online: 28 April 2022
Declarations
:
: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Lars G. Hvid has received travel grants and/or teaching honorary from Biogen and Sanofi Genzyme; Egon Stenager ES declare no conflict of interests; Ulrik Dalgas has received research support, travel grants and/or teaching honorary from Biogen, Merck Serono, Novartis, Bayer Schering and Sanofi Aventis as well as honoraria from serving on scientific meetings of Biogen and Sanofi Genzyme.
: This study was conducted in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments, and was approved by the ethics committee of the central Denmark region (record 1-10-72-223-16).